Literature DB >> 16639049

Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.

Paul A Gould1, Andrew D Krahn.   

Abstract

CONTEXT: Recent implantable cardioverter-defibrillator (ICD) advisories and recalls have caused management dilemmas for physicians, particularly because there are no specific guidelines or data on outcomes from current management strategies. The risk of ICD generator replacement has not been assessed in this population.
OBJECTIVE: To determine the complication rate associated with ICD generator replacement for the current ICD advisories. DESIGN AND
SETTING: Seventeen ICD implanting centers in Canada were surveyed to assess complication rates as a result of generator replacements because of ICD advisories from October 2004 to October 2005. MAIN OUTCOME MEASURE: Complications associated with elective ICD generator replacement for current device advisories.
RESULTS: At the 17 surveyed centers, 2915 patients had recall devices, including 533 (18.3%) who had advisory ICDs replaced a mean (SD) of 26.5 (11.5) months after their initial implant. Of these patients, 66% had a secondary prevention ICD, and 45% had received a previous appropriate shock. During a mean (SD) of 2.7 (2.8) months' follow-up after ICD generator replacement, complications occurred in 43 patients (8.1%). Major complications attributable to advisory device replacement requiring reoperation occurred in 31 patients (5.8%), with death in 2 patients after extraction for pocket infection. Minor complications occurred in 12 patients (2.3%). There were 3 (0.1%) advisory-related device malfunctions reported, without clinical consequences.
CONCLUSIONS: ICD generator replacement in patients with advisory devices is associated with a substantial rate of complications, including death. These complications need to be considered in the development of guidelines determining the appropriate treatment of patients with advisory devices.

Entities:  

Mesh:

Year:  2006        PMID: 16639049     DOI: 10.1001/jama.295.16.1907

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  58 in total

1.  The effect of device advisories on implantable cardioverter-defibrillator therapy.

Authors:  Mitesh S Amin; Kenneth A Ellenbogen
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

2.  Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.

Authors:  Jay Sengupta; Arthur C Kendig; Marlene Goormastic; Eui-Seock Hwang; Elizabeth A Ching; Roy Chung; Bruce D Lindsay; Patrick J Tchou; Bruce L Wilkoff; Mark J Niebauer; David O Martin; Niraj Varma; Oussama Wazni; Walid Saliba; Mohamed Kanj; Mandeep Bhargava; Thomas Dresing; Tyler Taigen; Christopher Ingelmo; Mohamed Bassiouny; Edmond M Cronin; Bradley Wilsmore; John Rickard; Mina K Chung
Journal:  Heart Rhythm       Date:  2012-07-03       Impact factor: 6.343

Review 3.  Gene therapy for ventricular tachyarrhythmias.

Authors:  J K Donahue
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

4.  Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?

Authors:  F A L E Bracke; L R C Dekker; P H van der Voort; A Meijer
Journal:  Neth Heart J       Date:  2009-03       Impact factor: 2.380

5.  [Single- and dual-chamber ICDs: Are there still significant differences compared to pacemakers with regard to implantation and follow-up?].

Authors:  M Stockburger
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-12

6.  Gene therapy approaches to ventricular tachyarrhythmias.

Authors:  J Kevin Donahue; Tetsuo Sasano; Kamilla Kelemen
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

7.  Molecular ablation of ventricular tachycardia after myocardial infarction.

Authors:  Tetsuo Sasano; Amy D McDonald; Kan Kikuchi; J Kevin Donahue
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

8.  Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.

Authors:  Manish Undavia; Nathan E Goldstein; Pilar Cohen; Kamoltip Sinthawanarong; Magdalena Singson; Divaya Bhutani; Tracey Munson; Joseph Anthony Gomes; Avi Fischer; Davendra Mehta
Journal:  Pacing Clin Electrophysiol       Date:  2008-11       Impact factor: 1.976

9.  Increasing lead burden correlates with externalized cables during systematic fluoroscopic screening of Riata leads.

Authors:  Liza P Moorman; J Randall Moorman; John P DiMarco; Rohit Malhotra; Andrew Darby; Kenneth Bilchick; John D Ferguson; J Michael Mangrum; Sandeep Kamath; Pamela K Mason
Journal:  J Interv Card Electrophysiol       Date:  2012-12-20       Impact factor: 1.900

10.  High efficiency electrodes for deep brain stimulation.

Authors:  Warren M Grill; Xuefeng F Wei
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.